Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Expert Review of Endocrinology & Metabolism|February 14, 2019
Growth hormone hypothesis and development of diabetic nephropathy in Type 1 diabetesRakesh Amin, David B DungerArchives of Disease in Childhood. Education and Practice Edition|July 30, 2017
Fifteen-minute consultation: Monogenic forms of diabetes with onset after age 6 monthsEmma M Dyer, Rakesh AminEuropean Journal of Endocrinology|September 9, 2008
'Do no harm': management of craniopharyngiomaHelena Gleeson, Rakesh Amin, Mohamad MaghniePatient Preference and Adherence|March 31, 2011
Developments in administration of growth hormone treatment: focus on Norditropin® Flexpro®Kevin C J Yuen, Rakesh AminPaediatric Drugs|August 17, 2013
Metformin in the treatment of obese children and adolescents at risk of type 2 diabetesDeborah L Kendall, Rakesh Amin, Peter E ClaytonBMJ Open Diabetes Research & Care|October 24, 2019
Cardiovascular risk factors from diagnosis in children with type 1 diabetes mellitus: a longitudinal cohort studyStephanie Jones, Amal R Khanolkar, Evelien Gevers, et al.Hormone Research in Paediatrics|December 23, 2014
Use of continuous glucose monitoring to identify glucose dysregulation in growth hormone insensitivity syndromeReena Perchard, Jemma Say, James Pitts, et al.The Journal of Pediatrics|January 15, 2004
Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndromeLourdes Ibáñez, Angela Ferrer, Ken Ong, et al.The Journal of Clinical Endocrinology and Metabolism|June 6, 2003
Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenismLourdes Ibáñez, Ken Ong, Angela Ferrer, et al.Pediatric Diabetes|May 11, 2017
Predictors of glycemic control in the first year of diagnosis of childhood onset type 1 diabetes: A systematic review of quantitative evidenceVeena Mazarello Paes, Dimitrios Charalampopoulos, Julie Edge, et al.Pageof 4